Understanding the Significance of Hypoxia-Inducible Factors (HIFs) in Glioblastoma: A Systematic Review.

Emir BegagićHakija BečulićAmina Džidić-KrivićSamra Kadić VukasSemir HadžićAlma Mekić-AbazovićSabina Šegalo Emsel Papić Emmanuel Muchai Echengi Ragib PugonjaTarik KasapovićDalila KavgićAdem NuhovićFatima Juković-BihoracSlavisa M Djuricic Mirza Pojskic

Published in: Cancers (2024)

Overcoming challenges such as treatment resistance and the absence of biomarkers is critical for the effective integration of HIF-related therapies into the treatment of glioblastoma with the aim of optimizing patient outcomes.

Keyphrases

endothelial cells
replacement therapy